國立虎尾科技大學 |

Success in the Bottom of the Pyramid Market in Africa = The Case of Multinational Pharmaceutical Companies /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Success in the Bottom of the Pyramid Market in Africa/ by Philipp von Carlowitz.
Reminder of title:	The Case of Multinational Pharmaceutical Companies /
Author:	von Carlowitz, Philipp.
Description:	XV, 120 p. 15 illus., 13 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Africa—Economic conditions. -
Online resource:	https://doi.org/10.1007/978-3-030-59068-0
ISBN:	9783030590680

Success in the Bottom of the Pyramid Market in Africa = The Case of Multinational Pharmaceutical Companies /
von Carlowitz, Philipp.

Success in the Bottom of the Pyramid Market in AfricaThe Case of Multinational Pharmaceutical Companies /[electronic resource] :by Philipp von Carlowitz. - 1st ed. 2020. - XV, 120 p. 15 illus., 13 illus. in color.online resource. - SpringerBriefs in Business,2191-5482. - SpringerBriefs in Business,.

This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently mentioned as an attractive market due to its sheer size. Yet most companies struggle to access it because of the low price level, difficult physical market access and challenges when it comes to payment. More specifically, the book investigates the following business model-related questions: Do pharmaceutical companies provide products that meet the needs of the BoP? What characterizes the value generation of the company? What revenue model leads to a profitable business, and what role does a network of partners play in the business model? Findings reveal that there is no ‘one-size-fits-all’ answer to these questions. Providing continuous availability, affordability at a good quality of goods and services, creating health awareness, as well as localizing business to achieve a level of inclusivenessare essential prerequisites for success. In the last chapter this book provides a business model prototype that accounts for these key success factors for business at the Bottom of the Pyramid and points to further research topics.

ISBN: 9783030590680

Standard No.: 10.1007/978-3-030-59068-0doiSubjects--Topical Terms:

1279443
Africa—Economic conditions.

LC Class. No.: HC800-1085

Dewey Class. No.: 330.0096

Success in the Bottom of the Pyramid Market in Africa = The Case of Multinational Pharmaceutical Companies /
LDR:02721nam a22003855i 4500 001 1023023
003 DE-He213
005 20201113205322.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030590680 $9 978-3-030-59068-0
024 7 $a 10.1007/978-3-030-59068-0 $2 doi
035 $a 978-3-030-59068-0
050 4 $a HC800-1085
072 7 $a KC $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KC $2 thema
082 0 4 $a 330.0096 $2 23
100 1 $a von Carlowitz, Philipp. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1271781
245 1 0 $a Success in the Bottom of the Pyramid Market in Africa $h [electronic resource] : $b The Case of Multinational Pharmaceutical Companies / $c by Philipp von Carlowitz.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a XV, 120 p. 15 illus., 13 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Business, $x 2191-5482
520 $a This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently mentioned as an attractive market due to its sheer size. Yet most companies struggle to access it because of the low price level, difficult physical market access and challenges when it comes to payment. More specifically, the book investigates the following business model-related questions: Do pharmaceutical companies provide products that meet the needs of the BoP? What characterizes the value generation of the company? What revenue model leads to a profitable business, and what role does a network of partners play in the business model? Findings reveal that there is no ‘one-size-fits-all’ answer to these questions. Providing continuous availability, affordability at a good quality of goods and services, creating health awareness, as well as localizing business to achieve a level of inclusivenessare essential prerequisites for success. In the last chapter this book provides a business model prototype that accounts for these key success factors for business at the Bottom of the Pyramid and points to further research topics.
650 0 $a Africa—Economic conditions. $3 1279443
650 0 $a International business enterprises. $3 557082
650 0 $a Sales management. $3 562612
650 0 $a Pharmacy management. $3 1236292
650 0 $a Globalization. $3 554884
650 0 $a Markets. $3 575391
650 0 $a Health care management. $3 1148454
650 0 $a Health services administration. $3 564005
650 1 4 $a African Economics. $3 1139822
650 2 4 $a African Business. $3 1141053
650 2 4 $a Sales/Distribution. $3 1102104
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 1063577
650 2 4 $a Emerging Markets/Globalization. $3 881676
650 2 4 $a Health Care Management. $3 1019864
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030590673
776 0 8 $i Printed edition: $z 9783030590697
830 0 $a SpringerBriefs in Business, $x 2191-5482 $3 1254463
856 4 0 $u https://doi.org/10.1007/978-3-030-59068-0
912 $a ZDB-2-ECF
912 $a ZDB-2-SXEF
950 $a Economics and Finance (SpringerNature-41170)
950 $a Economics and Finance (R0) (SpringerNature-43720)